flumazenil has been researched along with Cardiovascular Stroke in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sudzinova, A | 1 |
| Nagyova, I | 1 |
| Rosenberger, J | 1 |
| Studencan, M | 1 |
| Vargova, H | 1 |
| Middel, B | 1 |
| van Dijk, JP | 1 |
| Reijneveld, SA | 1 |
1 other study available for flumazenil and Cardiovascular Stroke
| Article | Year |
|---|---|
Seven years' mortality in Roma and non-Roma patients after coronary angiography.
Topics: Coronary Angiography; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarctio | 2015 |